Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

被引:51
|
作者
Giacometti, A
Cirioni, O
Del Prete, MS
Barchiesi, F
Paggi, AM
Petrelli, E
Scalise, G
机构
[1] Univ Ancona, Inst Infect Dis & Publ Hlth, Azienda Osped Umberto 1, I-60121 Ancona, Italy
[2] San Salvatore Hosp, Dept Infect Dis, Pescara, Italy
关键词
D O I
10.1093/jac/46.5.807
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of buforin II, cecropin P1, indolicidin, magainin II and ranalexin, alone and in combination with eight clinically used antimicrobial agents was investigated against 12 multidrug-resistant strains of Acinetobacter baumannii isolated from immunocompromised patients, Antimicrobial activities were measured by MIG, MBC and viable count, The peptides had a varied range of inhibitory values: overall, the organisms were more susceptible to buforin II (MIC range 0.25-16 mg/L), cecropin P1 (0.50-32 mg/L) and magainin II (0.50-16 mg/L), Synergy occurred when magainin II was combined with p-lactam antibiotics.
引用
收藏
页码:807 / 810
页数:4
相关论文
共 50 条
  • [1] Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates
    Seifert, Harald
    Stefanik, Danuta
    Wisplinghoff, Hilmar
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 1099 - 1100
  • [2] Antimicrobial and antibiofilm activities of desloratadine against multidrug-resistant Acinetobacter baumannii
    Eduvirgem, Junio
    Rossato, Luana
    Melo, Andressa Lf
    Valiente, Anna Cm
    Placa, Luiz F.
    Wender, Heberton
    Vaz, Marcia Sm
    Ribeiro, Suzana M.
    Simionatto, Simone
    FUTURE MICROBIOLOGY, 2023, 18 (01) : 15 - 25
  • [3] Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates
    Kiratisin, Pattarachai
    Apisarnthanarak, Anucha
    Kaewdaeng, Srirumpa
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (03) : 243 - 246
  • [4] In Vitro and In Vivo Antimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii
    Antunes, Luisa C. S.
    Imperi, Francesco
    Minandri, Fabrizia
    Visca, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5961 - 5970
  • [5] Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates
    Piewngam, Pipat
    Kiratisin, Pattarachai
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (05) : 396 - 401
  • [6] Nosocomial infection of multidrug-resistant Acinetobacter baumannii in Thailand
    Anudit, Chanihcha
    Kooltheat, Nateelak
    Potup, Pachuen
    Sranujit, Rungnapa Pankla
    Usuwanthim, Kanchana
    AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (10) : 1161 - 1163
  • [7] Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii
    Adibhesami, H.
    Douraghi, M.
    Rahbar, M.
    Abdollahi, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (11) : E79 - E80
  • [8] Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
    Lin, Chun-Hsien
    Lee, Mong-Chuan
    Tzen, Jason T. C.
    Lee, Hsien-Ming
    Chang, Sam-Min
    Tu, Wu-Chun
    Lin, Chuen-Fu
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (05) : 1023 - 1029
  • [9] Secapin: a promising antimicrobial peptide against multidrug-resistant Acinetobacter baumannii
    Rad, Zohreh Sadeghi
    Farahmand, Mahnaz
    Kavousi, Mahsa
    GMS HYGIENE AND INFECTION CONTROL, 2024, 19
  • [10] EMERGENCE OF MULTIDRUG-RESISTANT ISOLATES OF ACINETOBACTER-BAUMANNII
    OKPARA, AU
    MASWOSWE, JJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (21): : 2671 - 2675